Cargando…

Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

Detalles Bibliográficos
Autores principales: Sacco, Simona, Bendtsen, Lars, Ashina, Messoud, Reuter, Uwe, Terwindt, Gisela, Mitsikostas, Dimos-Dimitrios, Martelletti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734242/
https://www.ncbi.nlm.nih.gov/pubmed/31122188
http://dx.doi.org/10.1186/s10194-019-0972-5
_version_ 1783450111809945600
author Sacco, Simona
Bendtsen, Lars
Ashina, Messoud
Reuter, Uwe
Terwindt, Gisela
Mitsikostas, Dimos-Dimitrios
Martelletti, Paolo
author_facet Sacco, Simona
Bendtsen, Lars
Ashina, Messoud
Reuter, Uwe
Terwindt, Gisela
Mitsikostas, Dimos-Dimitrios
Martelletti, Paolo
author_sort Sacco, Simona
collection PubMed
description
format Online
Article
Text
id pubmed-6734242
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-67342422019-09-12 Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention Sacco, Simona Bendtsen, Lars Ashina, Messoud Reuter, Uwe Terwindt, Gisela Mitsikostas, Dimos-Dimitrios Martelletti, Paolo J Headache Pain Correction Springer Milan 2019-05-23 /pmc/articles/PMC6734242/ /pubmed/31122188 http://dx.doi.org/10.1186/s10194-019-0972-5 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Sacco, Simona
Bendtsen, Lars
Ashina, Messoud
Reuter, Uwe
Terwindt, Gisela
Mitsikostas, Dimos-Dimitrios
Martelletti, Paolo
Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
title Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
title_full Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
title_fullStr Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
title_full_unstemmed Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
title_short Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
title_sort correction to: european headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6734242/
https://www.ncbi.nlm.nih.gov/pubmed/31122188
http://dx.doi.org/10.1186/s10194-019-0972-5
work_keys_str_mv AT saccosimona correctiontoeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention
AT bendtsenlars correctiontoeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention
AT ashinamessoud correctiontoeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention
AT reuteruwe correctiontoeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention
AT terwindtgisela correctiontoeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention
AT mitsikostasdimosdimitrios correctiontoeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention
AT martellettipaolo correctiontoeuropeanheadachefederationguidelineontheuseofmonoclonalantibodiesactingonthecalcitoningenerelatedpeptideoritsreceptorformigraineprevention